Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (5 quarters reported)
$174M in Q4 2021 → $53.6M now. Hover for any quarter.
As reported for the quarter ended December 31, 2022. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Eqrx Inc | 64.0% | Unchanged | 13,935,623 | $34.3M |
| PT Pear Therapeutics Inc | 23.9% | Unchanged | 10,859,050 | $12.8M |
| Inogen Inc | 12.1% | Unchanged | 330,000 | $6.5M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 4 quarters.
quarter ended December 31, 2022 · filed January 25, 2023
No position changes this quarter.
quarter ended September 30, 2022 · filed November 08, 2022
No position changes this quarter.
quarter ended June 30, 2022 · filed July 22, 2022
No position changes this quarter.
quarter ended March 31, 2022 · filed May 11, 2022
No position changes this quarter.
Loading...
